June 5th 2024, 1:00pm
Learning that I had cancer — melanoma and renal cell carcinoma — made me feel like I lost something, but I keep looking ahead.
June 1st 2024, 5:00pm
Eight-year follow-up showed that Tafinlar plus Mekinist continued to improve outcomes for patients with stage 3 melanoma.
May 8th 2024, 3:00pm
The Food and Drug Administration granted a Biologics License Application for subcutaneous Opdivo for potential approval.
April 23rd 2024, 1:00pm
When my wife was diagnosed with stage 3B melanoma, we decided to openly speak about our fears.
April 17th 2024, 3:00pm
A type of therapy that involves “liberating” T cells from a suppressive tumor environment showed promise in the treatment of patients with uveal melanoma.
April 10th 2024, 3:00pm
An expert explained the importance of patient choice in treatment decisions for high-risk, resectable melanoma, based on their own treatment goals.
April 5th 2024, 7:00pm
Since January 2024, the Food and Drug Administration has approved several treatments and combinations for solid tumors.
April 3rd 2024, 7:00pm
A vaccine developer discusses a cancer vaccine that has been shown to potentially boost long-term overall postsurgical survival.
April 2nd 2024, 3:00pm
Melanoma survivors may have an increased risk of recurrence, which may heighten fear and worry, but “it’s OK and normal to be worried,” a doctor said.
March 29th 2024, 3:00pm
From Fortnight player, “Ninja” announcing his melanoma diagnosis to an LSU quarterback sporting the name of his teammate with brain cancer, here’s what’s going on in the oncology space this week.
Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation
Sasanlimab-BCG Combo May Delay Recurrence in Bladder Cancer
Personalized Vaccine Elicits Responses in Patients With Kidney Cancer
The Invisibility of Blood Cancers to Others